Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

4.870 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,318
Open 4.870
Bid (Size) 4.880 (1)
Ask (Size) 4.920 (1)
Prev. Close 4.870
Today's Range 4.870 - 4.870
52wk Range 1.260 - 7.300
Shares Outstanding 191,500,944
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes
An update on Sana Biotechnology. 
Via Benzinga
Kroger Posts Better-Than-Expected Earnings, Joins Couchbase, CarMax And Other Big Stocks Moving Higher On Friday
Via Benzinga

Performance

YTD
+195.2%
+195.2%
1 Month
+87.3%
+87.3%
3 Month
+181.5%
+181.5%
6 Month
+66.8%
+66.8%
1 Year
-20.3%
-20.3%

More News

Read More
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
From Sana Biotechnology, Inc
Via GlobeNewswire
Two Biotech Stocks Poised For Big Moves On Monday
Via Benzinga
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
Via Benzinga
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
From Sana Biotechnology, Inc
Via GlobeNewswire
Sana Biotechnology to Present at June 2025 Investor Conferences
From Sana Biotechnology, Inc
Via GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
From Faruqi & Faruqi, LLP
Via Business Wire
The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
SANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
From Sana Biotechnology, Inc
Via GlobeNewswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, A RANKED AND LEADING FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
From The Rosen Law Firm PA
Via GlobeNewswire

Frequently Asked Questions

Is Sana Biotechnology, Inc. - Common Stock publicly traded?
Yes, Sana Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Sana Biotechnology, Inc. - Common Stock trade on?
Sana Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sana Biotechnology, Inc. - Common Stock?
The ticker symbol for Sana Biotechnology, Inc. - Common Stock is SANA on the Nasdaq Stock Market
What is the current price of Sana Biotechnology, Inc. - Common Stock?
The current price of Sana Biotechnology, Inc. - Common Stock is 4.870
When was Sana Biotechnology, Inc. - Common Stock last traded?
The last trade of Sana Biotechnology, Inc. - Common Stock was at 07/22/25 04:00 PM ET
What is the market capitalization of Sana Biotechnology, Inc. - Common Stock?
The market capitalization of Sana Biotechnology, Inc. - Common Stock is 932.61M
How many shares of Sana Biotechnology, Inc. - Common Stock are outstanding?
Sana Biotechnology, Inc. - Common Stock has 933M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.